MedPath

Effect of beclomethasone in the control of pediatric asthma

Not Applicable
Conditions
Pediatric Persistent Asthma.
Predominantly allergic asthma
Registration Number
IRCT2017092036286N1
Lead Sponsor
Vice- Chancellor for Research Technology Affairs, Babol University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Pediatrics aged 6 to 10 years; Pediatrics with persistent asthma symptoms; referred to the Center during the study;
Exclusion criteria: Pediatrics with lung infections; Pediatrics any underlying illness such as simultaneous cardiac disease; Antihistamine use; Having any illness; Taking other medications;

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
FEV1. Timepoint: Before and 3 months after treatment. Method of measurement: With spirometry.
Secondary Outcome Measures
NameTimeMethod
Go to school. Timepoint: At the end of the treatment. Method of measurement: Take report from parent and completion in the questionnaire.;Night sleep quality (sleep deprivation). Timepoint: At the end of the treatment. Method of measurement: Take report from parent and completion in the questionnaire.
© Copyright 2025. All Rights Reserved by MedPath